About Christelle Johnson, MS, PhD

Senior Field Application Specialist Cancer Genomics & Immuno-Oncology Dr. Johnson joined Personalis, Inc. in 2015 as Field Applications Scientist with ten years of basic and translational research experience in cancer immunogenomics, metabolism, and metastasis, and has authored over 15 publications in the cancer field. In her role at Personalis, Christelle provides scientific technical support and consumer education on the ACE Cancer Product Portfolio. Prior to joining Personalis, Christelle completed her postdoctoral studies at Harvard Medical School and Cornell University investigating the role of the tumor microenvironment in promoting disease progression. She received her PhD in Cancer Immunology from the University of Louisville School of Medicine.
24 Feb, 2021

Neoantigen-based Cancer Therapies

Christelle Johnson, MS, PhD Senior Field Applications Scientist Cancer Genomics & Immuno-Oncology Neoantigen-based cancer immunotherapies We are witnessing one of the most accelerated scientific efforts in response to the COVID-19 pandemic.  Among these efforts that include sequencing the virus, designing the very first prophylactic vaccines, conducting clinical trials, demonstrating efficacy, [...]

3 Nov, 2020

Comprehensive Immunogenomics Profiling for the Discovery of the Next Generation of Oncology Biomarkers

Christelle Johnson, MS, PhD Senior Field Applications Scientist Cancer Genomics & Immuno-Oncology Comprehensive Immunogenomics Profiling for the Discovery of the Next Generation of Oncology Biomarkers Although hypothesized back in the early 1900s that the immune system may provide a protective mechanism against tumorigenesis, only recently have the fields of immunology [...]

1 Sep, 2016

Genomics at the core of cancer immunotherapy efficacy

Christelle Johnson, MS, PhD Field Applications Scientist Genomics at the core of cancer immunotherapy efficacy We owe much of the progress in cancer immunotherapy to the understanding of basic science. Decades of research have helped establish hallmarks of cancer, which include a complex battle between oncogenes and tumor suppressor genes [...]

Go to Top